Monday, August 29, 2016

Today's Research Daily features 16 fresh analyst reports on major stocks, including Allergan (AGN), Occidental Petroleum (OXY) and Apple (AAPL). These research reports have been hand-picked from the roughly 75 research reports issued by our analyst team today. You can see the full list of today's research reports here >>>

Apple shares have lagged the broader market lately on concerns about the iPhone maker's long-term growth trajectory, particulalry with questions about China not going away. These issues notwithstanding, the company remains optimistic about growth in regions like India and a decent rebound in China with the coming iPhone 7 launch, with growth getting a boost from the upgrade cycle even in mature markets. The stock should be attractive to value-oriented investors as well given the company's reasonable valuation and impressive track record of returning excess cash to shareholders through buybacks and dividends. (You can read the full research report on Apple here>>)

Allergan has been through so many transformative M&A transactions over the last few years that it has little in common with what it was just a couple of years back. The recent sale of the generics business to Teva is expected to increase focus on the branded portfolio and also use the proceeds for share buybacks and strenthening the balance sheet. Market participants appear skeptical of Allergan's near-term direction, as reflected in the stock's recent uderperformance The analyst discusses the pros & cons of investing in Allergan shares at this level. (You can read the full research report on Allergan here>>)

Occidental Petroleum shares will continue to move inline with oil prices, as is the case with all the other producers. But what distinguishes Occidental from other producers is its strong balance sheet and positive production growth profile despite a very disciplined capital program. The company's stable chemical and mid-stream assets add to its allure, as is its safe (and growing) dividend, currently yielding 3.9%. We have long liked Occidental as a long-term holding and have it in the Zacks Focus List as well. (You can read the full research report on Occidental here>>)

Free Access: All Zacks Research Reports
Starting today, you are invited to download in-depth analysis reports covering more than 1,000 of the most widely followed stocks. Valued at $25 each, they are yours to consult over the next 30 days absolutely free. They feature sensitive Zacks Rank information on each stock that you won't find anywhere else. See the reports free >>

You can find all of today's stock research reports here>>

Sheraz Mian

Director of Research

If you want an email notification each time Sheraz publishes a new article, please click here >>